BIO
ReciBioPharm is advancing xRNA manufacture by implementing novel process analytical technologies on a continuous manufacturing platform with powerful impact on shortened timelines, efficient quality control, and lowered costs. Through shortening time to first-in-human trials and increasing efficiency, this approach opens new opportunities for therapy developers and expands global patient access to life-saving treatments.
Fill in the form below and watch the webinar.